Georgetown University

🇬🇹Guatemala

Country: 🇬🇹Guatemala

Ownership: Private

Established: 1789-01-23

Employees: 5K

Market Cap: -

Website: http://www.georgetown.edu

Clinical Trials

Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer

Phase 1

Completed

Conditions: Small Cell Lung Cancer Extensive Stage
Small Cell Lung Cancer

Interventions: Drug: Nivolumab
Radiation: 177Lu-DOTA0-Tyr3-Octreotate

First Posted Date: 2017-10-30

Last Posted Date: 2021-03-16

Lead Sponsor: Georgetown University

Target Recruit Count: 9

Registration Number: NCT03325816

Locations: 🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

Psychosocial Intervention Pilot for Partners in BRCA Testing

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: psychosocial counseling

First Posted Date: 2017-10-27

Last Posted Date: 2017-10-27

Lead Sponsor: Georgetown University

Target Recruit Count: 10

Registration Number: NCT03323333

Pediatric Health Promotion Program

Not Applicable

Completed

Conditions: Tobacco Use

Interventions: Behavioral: Provider Advice, Framed Messaging

First Posted Date: 2017-10-26

Last Posted Date: 2019-01-18

Lead Sponsor: Georgetown University

Target Recruit Count: 350

Registration Number: NCT03322501

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States

Comparing the Clinical Outcomes of DermACELL® With Integra® Bilayer Wound Matrix

Not Applicable

Conditions: Chronic Wounds
Nonmalignant Condition
Wounds

Interventions: Device: DermACELL®
Device: Integra®

First Posted Date: 2017-09-18

Last Posted Date: 2020-03-11

Lead Sponsor: Georgetown University

Target Recruit Count: 53

Registration Number: NCT03285698

Locations: 🇺🇸
Medstar Georgetown University Hospital, Washington, District of Columbia, United States

Evaluating the Outcomes for Incisional Application of Negative Pressure for Nontraumatic Amputations

Not Applicable

Conditions: Wound Heal
Surgical Wound
Amputation

Interventions: Other: Standard Dry Dressing
Device: PrevenaTM Device

First Posted Date: 2017-08-15

Last Posted Date: 2019-09-25

Lead Sponsor: Georgetown University

Target Recruit Count: 112

Registration Number: NCT03250442

Locations: 🇺🇸
Medstar Georgetown University Hospital, Washington, District of Columbia, United States

Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies

Phase 1

Terminated

Conditions: Solid Tumor, Adult
Homologous Recombination Deficiency

Interventions: Drug: Niraparib
Drug: Carboplatin

First Posted Date: 2017-07-06

Last Posted Date: 2024-02-05

Lead Sponsor: Georgetown University

Target Recruit Count: 23

Registration Number: NCT03209401

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States
🇺🇸
Sibley Memorial Hospital, Washington, District of Columbia, United States
🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

and more 2 locations

Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli

Not Applicable

Completed

Conditions: Generalized Anxiety Disorder
Post Traumatic Stress Disorder
Agoraphobia
Social Anxiety Disorder
Panic Disorder
Simple Phobia
Anxiety Disorders

Interventions: Behavioral: Mindfulness-Based Stress Reduction
Behavioral: Waitlist

First Posted Date: 2017-07-02

Last Posted Date: 2022-12-23

Lead Sponsor: Georgetown University

Target Recruit Count: 45

Registration Number: NCT03206437

Locations: 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States

The Lung Screening, Tobacco and Health Project

Phase 3

Completed

Conditions: Lung Cancer Screening
Smoking, Tobacco
Tobacco-Related Carcinoma
Tobacco Use

Interventions: Behavioral: Intensive Telephone Counseling (8 sessions) with nicotine replacement

First Posted Date: 2017-06-27

Last Posted Date: 2023-11-02

Lead Sponsor: Georgetown University

Target Recruit Count: 1114

Registration Number: NCT03200236

Locations: 🇺🇸
Baptist Health South Florida, Miami, Florida, United States
🇺🇸
Lahey Hospital and Medical Center, Burlington, Massachusetts, United States
🇺🇸
MedStar Shah Medical Group, Hollywood, Maryland, United States

and more 4 locations

Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy

Phase 2

Terminated

Conditions: Thymoma
Advanced Thymic Epithelial Tumor

Interventions: Drug: Open Label Selinexor

First Posted Date: 2017-06-20

Last Posted Date: 2023-02-16

Lead Sponsor: Georgetown University

Target Recruit Count: 8

Registration Number: NCT03193437

Locations: 🇺🇸
John Theurer Cancer Center - Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

MEND 2: Making Treatment Decisions Using Genomic Testing

Not Applicable

Completed

Conditions: Breast Cancer Female

Interventions: Behavioral: Question Prompt List

First Posted Date: 2017-06-09

Last Posted Date: 2021-09-21

Lead Sponsor: Georgetown University

Target Recruit Count: 80

Registration Number: NCT03183050

Locations: 🇺🇸
Medstar Cancer Network, Washington, District of Columbia, United States
🇺🇸
H. Lee Moffitt Cancer Center, Tampa, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy